Cargando…

Incorporation of Ebola glycoprotein into HIV particles facilitates dendritic cell and macrophage targeting and enhances HIV-specific immune responses

The development of an effective vaccine against HIV infection remains a global priority. Dendritic cell (DC)-based HIV immunotherapeutic vaccine is a promising approach which aims at optimizing the HIV-specific immune response using primed DCs to promote and enhance both the cellular and humoral arm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ao, Zhujun, Wang, Lijun, Mendoza, Emelissa J., Cheng, Keding, Zhu, Wenjun, Cohen, Eric A., Fowke, Keith, Qiu, Xiangguo, Kobinger, Gary, Yao, Xiaojian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524799/ https://www.ncbi.nlm.nih.gov/pubmed/31100082 http://dx.doi.org/10.1371/journal.pone.0216949

Ejemplares similares

Development and Evaluation of an Ebola Virus Glycoprotein Mucin-Like Domain Replacement System as a New Dendritic Cell-Targeting Vaccine Approach against HIV-1
por: Ao, Zhujun, et al.
Publicado: (2021)

Dendritic Cells/Macrophages-Targeting Feature of Ebola Glycoprotein and its Potential as Immunological Facilitator for Antiviral Vaccine Approach
por: Olukitibi, Titus Abiola, et al.
Publicado: (2019)

Characterization of the inhibitory effect of an extract of Prunella vulgaris on Ebola virus glycoprotein (GP)-mediated virus entry and infection
por: Zhang, Xu, et al.
Publicado: (2016)

HIV-1 envelope glycoprotein stimulates viral transcription and increases the infectivity of the progeny virus through the manipulation of cellular machinery
por: Ran, Xiaozhuo, et al.
Publicado: (2017)

Contribution of the C-terminal tri-lysine regions of human immunodeficiency virus type 1 integrase for efficient reverse transcription and viral DNA nuclear import
por: Ao, Zhujun, et al.
Publicado: (2005)

The Roles of Ebola Virus Soluble Glycoprotein in Replication, Pathogenesis, and Countermeasure Development
por: Zhu, Wenjun, et al.
Publicado: (2019)

Transient Liver Damage and Hemolysis Are Associated With an Inhibition of Ebola Virus Glycoprotein-Specific Antibody Response and Lymphopenia
por: Fausther-Bovendo, Hugues, et al.
Publicado: (2021)

R88-APOBEC3Gm Inhibits the Replication of Both Drug-resistant Strains of HIV-1 and Viruses Produced From Latently Infected Cells
por: Wang, Xiaoxia, et al.
Publicado: (2014)

Noncovalent SUMO-interaction motifs in HIV integrase play important roles in SUMOylation, cofactor binding, and virus replication
por: Zheng, Yingfeng, et al.
Publicado: (2019)

Immunization with vesicular stomatitis virus vaccine expressing the Ebola glycoprotein provides sustained long-term protection in rodents
por: Wong, Gary, et al.
Publicado: (2014)

Vpr14-88-Apobec3G Fusion Protein Is Efficiently Incorporated into Vif-Positive HIV-1 Particles and Inhibits Viral Infection
por: Ao, Zhujun, et al.
Publicado: (2008)

The Cytokine Response Profile of Ebola Virus Disease in a Large Cohort of Rhesus Macaques Treated With Monoclonal Antibodies
por: Banadyga, Logan, et al.
Publicado: (2019)

Development and characterization of influenza M2 ectodomain and/or hemagglutinin stalk-based dendritic cell-targeting vaccines
por: Olukitibi, Titus Abiola, et al.
Publicado: (2022)

Current Advances in Virus-Like Particles as a Vaccination Approach against HIV Infection
por: Zhao, Chongbo, et al.
Publicado: (2016)

Atypical Ebola Virus Disease in a Nonhuman Primate following Monoclonal Antibody Treatment Is Associated with Glycoprotein Mutations within the Fusion Loop
por: Banadyga, Logan, et al.
Publicado: (2021)

Characterization of the Role of Host Cellular Factor Histone Deacetylase 10 during HIV-1 Replication
por: Ran, Xiaozhuo, et al.
Publicado: (2019)

Purification and characterization of monoclonal IgG antibodies recognizing Ebola virus glycoprotein
por: Han, Baek-Sang, et al.
Publicado: (2018)

Ebola GP-Specific Monoclonal Antibodies Protect Mice and Guinea Pigs from Lethal Ebola Virus Infection
por: Qiu, Xiangguo, et al.
Publicado: (2012)

Pseudotyping of VSV with Ebola virus glycoprotein is superior to HIV-1 for the assessment of neutralising antibodies
por: Steeds, Kimberley, et al.
Publicado: (2020)

Naturally Occurring Single Mutations in Ebola Virus Observably Impact Infectivity
por: Wong, Gary, et al.
Publicado: (2018)

Retromer Regulates HIV-1 Envelope Glycoprotein Trafficking and Incorporation into Virions
por: Groppelli, Elisabetta, et al.
Publicado: (2014)

BoHV-4-based vector delivering Ebola virus surface glycoprotein
por: Rosamilia, Alfonso, et al.
Publicado: (2016)

Development of an HIV vaccine using a vesicular stomatitis virus vector expressing designer HIV-1 envelope glycoproteins to enhance humoral responses
por: Racine, Trina, et al.
Publicado: (2017)

Modeling Ebola Virus Transmission Using Ferrets
por: de La Vega, Marc-Antoine, et al.
Publicado: (2018)

Preventing HIV infection without targeting the virus: how reducing HIV target cells at the genital tract is a new approach to HIV prevention
por: Lajoie, Julie, et al.
Publicado: (2017)

Characterization of the HIV-1 integrase chromatin- and LEDGF/p75-binding abilities by mutagenic analysis within the catalytic core domain of integrase
por: Zheng, Yingfeng, et al.
Publicado: (2010)

Characterization of a Bivalent Vaccine Capable of Inducing Protection Against Both Ebola and Cross-clade H5N1 Influenza in Mice
por: Wong, Gary, et al.
Publicado: (2015)

Molecular Characterization of the Monoclonal Antibodies Composing ZMAb: A Protective Cocktail Against Ebola Virus
por: Audet, Jonathan, et al.
Publicado: (2014)

Characterization of the receptor-binding domain of Ebola glycoprotein in viral entry
por: Wang, Jizhen, et al.
Publicado: (2011)

The Ebola Virus Glycoprotein and HIV-1 Vpu Employ Different Strategies to Counteract the Antiviral Factor Tetherin
por: Kühl, Annika, et al.
Publicado: (2011)

HIV and Ebola: similarities and differences
por: Wainberg, Mark A, et al.
Publicado: (2014)

Global Rescue of Defects in HIV-1 Envelope Glycoprotein Incorporation: Implications for Matrix Structure
por: Tedbury, Philip R., et al.
Publicado: (2013)

Sustained protection against Ebola virus infection following treatment of infected nonhuman primates with ZMAb
por: Qiu, Xiangguo, et al.
Publicado: (2013)

Activation of HIV-1 expression in latently infected CD4+ T cells by the small molecule PKC412
por: Ao, Zhujun, et al.
Publicado: (2016)

Recombinant Antibodies to the Ebola Virus Glycoprotein
por: Panina, A. A., et al.
Publicado: (2017)

Commentary: MARCH8 Inhibits HIV-1 Infection by Reducing Virion Incorporation of Envelope Glycoproteins
por: Fujita, Mikako
Publicado: (2016)

Antigenic characterization of the human immunodeficiency virus (HIV-1) envelope glycoprotein precursor incorporated into nanodiscs
por: Witt, Kristen C., et al.
Publicado: (2017)

Ebola Virus RNA in Semen from an HIV-Positive Survivor of Ebola
por: Purpura, Lawrence J., et al.
Publicado: (2017)

Inactivation of microbial infectiousness by silver nanoparticles-coated condom: a new approach to inhibit HIV- and HSV-transmitted infection
por: Mohammed Fayaz, A, et al.
Publicado: (2012)

Roles, function and relevance of LAG3 in HIV infection
por: Graydon, Colin G., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ffanefec9frbt6416v3ubeinnc